All News #Library
Generics
Emcure Pharma Cuts Poviztra Starting Dose Price By 55% In India
02 Apr 2026 //
INDPHARMAPOST
Emcure Pharma partners with Gilead Sciences to produce HIV drug
04 Oct 2024 //
PRESS RELEASE
Gilead inks licensing deals to boost lenacapivir access
02 Oct 2024 //
FIERCE PHARMA
Emcure launches generic drug for hyperphosphatemia in chronic kidney disease
02 Jul 2020 //
ECONOMICTIMES
Emcure launches India first generic version of sucroferric oxyhydroxide for CKD
01 Jul 2020 //
EXPRESSPHARMA
Emcure launches knock-off of Eisai`s cancer drug Halaven at 40% lower price
03 Apr 2019 //
MONEYCONTROL
Senispar (cinacalcet hydrochloride) : Amgen vs. Emcure Pharmaceuticals
15 Sep 2018 //
PATENT LITIGATION
Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
18 Jul 2018 //
PATENT LITIGATION
Latuda® (Lurasidone Hcl): Sumitomo Dainippon Pharma v. Emcure Pharmaceuticals
13 Feb 2018 //
PATENT LITIGATION
Mylan President, Emcure Exec Targeted by States in Generic Drug Lawsuit
31 Oct 2017 //
THESTREET
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Emcure Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
The Man The Feds Are Using To First Crack Open Their Big Antitrust Case
15 Dec 2016 //
FORBES

Market Place
Sourcing Support